Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A Multicenter, Prospective, Observational Study of Pola-R-CHP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (POLASTAR): A Preliminary Analysis

Blood (2024) 144 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2024-192949

Published: 2024

Journal Articles

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Blood (2023) 142 (Supplement 1): 1762.

https://doi.org/10.1182/blood-2023-174647

Published: 2023

Journal Articles

Screening for Intracellular Phosphorylation Cascades That Positively and Negatively Regulate the Self-Renewing Proliferation of Immature HPCs

Sayaka Kitada, Yoko Nishinaka-Arai, Momoko Nishikori, Akira Niwa, Megumu K Saito

Blood (2023) 142 (Supplement 1): 4055.

https://doi.org/10.1182/blood-2023-183086

Published: 2023

Journal Articles

Enhancement of Human Neutrophil Bactericidal Activity through ROS Regulation

Misato Komori, Yoko Nishinaka-Arai, Momoko Nishikori, Akira Niwa, Megumu K Saito

Blood (2023) 142 (Supplement 1): 673.

https://doi.org/10.1182/blood-2023-180505

Published: 2023

Journal Articles

LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells

Tomoyasu Jo, Momoko Nishikori, Yasunori Kogure, Hiroshi Arima, Katsuhiro Sasaki, Yoshiteru Sasaki, Tomoko Nakagawa, Fumie Iwai, Shuji Momose, Aki Shiraishi, Hiroshi Kiyonari, Noritaka Kagaya, Tetsuo Onuki, Kazuo Shin-ya, Minoru Yoshida, Keisuke Kataoka, Seishi Ogawa, Kazuhiro Iwai, Akifumi Takaori-Kondo

Blood (2020) 136 (6): 684–697.

https://doi.org/10.1182/blood.2019002654

Published: 2020

Includes: Supplemental data

Journal Articles

End-of-Treatment 18[F]-FDG PET Can Predict Progression-Free Survival in Patients Undergoing Bendamustine + Rituximab for First Relapsed/Recurrent Follicular Lymphoma: The Result of W- J H S NHL01 Study

Shinya Rai, MD PhD, Koji Kato, MD PhD, Junji Suzumiya, MD PhD, Koji Izutsu, MD PhD, Momoko Nishikori, MD PhD, Hirohiko Shibayama, MD PhD, Yoshinobu Maeda, MD PhD, Kenichi Yoshimura, PhD, Ukihide Tateishi, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tsutomu Takahashi, MD PhD, Takahiro Yamauchi, MD PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2019) 134 (Supplement_1): 5245.

https://doi.org/10.1182/blood-2019-126455

Published: 2019

Journal Articles

Clinical Analysis of Immunodeficiency-Associated Lymphoproliferative Disorders in a Single Institution

Mizuki Watanabe, MD, Junya Kanda, MD, Yasuyuki Arai, MD PhD, Momoko Nishikori, MD PhD, Masakatsu Hishizawa, MD PhD, Tadakazu Kondo, MD PhD, Kouhei Yamashita, MD PhD, Akifumi Kondo Takaori, MD PhD

Blood (2018) 132 (Supplement 1): 5398.

https://doi.org/10.1182/blood-2018-99-115532

Published: 2018

Journal Articles

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Tomoyasu Jo, MD, Momoko Nishikori, MD PhD, Yoshiteru Sasaki, MD PhD, Yasunori Kogure, MD PhD, Keisuke Kataoka, MD PhD, Seishi Ogawa, MD PhD, Kazuhiro Iwai, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2018) 132 (Supplement 1): 775.

https://doi.org/10.1182/blood-2018-99-111097

Published: 2018

Journal Articles

Notch1-Activated B Cells Have an Immunomodulatory Function Enhancing Th2 and Treg Immune Response Via IL-33-ST2 Pathway

Hiroshi Arima, MD, Momoko Nishikori, MD PhD, Yasuyuki Otsuka, MD, Kiyotaka Izumi, MD, Wataru Kishimoto, MD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 130.

https://doi.org/10.1182/blood.V128.22.130.130

Published: 2016

Journal Articles

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Blood (2016) 128 (22): 3029.

https://doi.org/10.1182/blood.V128.22.3029.3029

Published: 2016

Journal Articles

Expression of Tim-1 and Its Pathogenetic Role in Primary CNS Lymphoma

Momoko Nishikori, MD, PhD, Wataru Kishimoto, MD, Hiroshi Arima, MD, Kotaro Shirakawa, MD, PhD, Toshio Kitawaki, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2014) 124 (21): 2961.

https://doi.org/10.1182/blood.V124.21.2961.2961

Published: 2014

Journal Articles

STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

Noriaki Yoshida, MD, Shinobu Tsuzuki, MD PhD, Kennosuke Karube, MD PhD, Miyuki Katayama, MD PhD, Taishi Takahara, MD, Shigeo Nakamura, MD PhD, Momoko Nishikori, MD, PhD, Masanori Shimoyama, MD PhD, Koichi Ohshima, MD PhD, Kunihiro Tsukasaki, MD PhD, Masao Seto, MD PhD

Blood (2014) 124 (21): 1615.

https://doi.org/10.1182/blood.V124.21.1615.1615

Published: 2014

Journal Articles

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

Dai Chihara, MD PhD, Naoko Asano, MD PhD, Ohmachi Ken, Momoko Nishikori, MD, PhD, Masataka Okamoto, Masashi Sawa, Rika Sakai, MD PhD, Yasushi Okoshi, MD PhD, Norifumi Tsukamoto, MD PhD, Yoshihiro Yakushijin, MDPhD, Shigeo Nakamura, MD PhD, Tomohiro Kinoshita, Michinori Ogura, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2014) 124 (21): 1660.

https://doi.org/10.1182/blood.V124.21.1660.1660

Published: 2014

Journal Articles

Deregulation of CCND1 or BCL2 in the Immature B-Cell Stage Determines the Resulting Lymphoma Histology

Masaharu Tashima, MD, Momoko Nishikori, MD, PhD, Wataru Kishimoto, MD, Ryo Yamamoto, MD, PhD, Tomomi Sakai, MD. PhD, Katsuyuki Ohmori, PhD, Shinobu Tsuzuki, MD, PhD, Masao Seto, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2012) 120 (21): 416.

https://doi.org/10.1182/blood.V120.21.416.416

Published: 2012

Journal Articles

Idiopathic CD4 Lymphocytopenia Due to Loss of Heterozygosity of the Mutant CD2 Gene

Masaharu Tashima, MD, Momoko Nishikori, MD, PhD, Toshio Kitawaki, MD, PhD, Masakatsu Hishizawa, MD, PhD, Taisuke Izumi, PhD, Yayoi Fujiwara, MD, Minako Mori, MD, Kaori Kihara, MD, Katsuyuki Ohmori, PhD, Tadakazu Kondo, MD, PhD, Takayuki Ishikawa, MD, PhD, Akifumi Takaori-Kondo, MD, PhD

Blood (2010) 116 (21): 2774.

https://doi.org/10.1182/blood.V116.21.2774.2774

Published: 2010

Journal Articles

B Cells with BCL2/IGH Translocation Compose a Distinctive Cell Population That May Serve as a Reservoir of Lymphoma of Germinal Center B-Cell Type.

Tomomi Sakai, Momoko Nishikori, Masaharu Tashima, Ryo Yamamoto, Toshio Kitawaki, Akifumi Takaori-Kondo, Shinobu Tsuzuki, Takashi Uchiyama

Blood (2008) 112 (11): 2050.

https://doi.org/10.1182/blood.V112.11.2050.2050

Published: 2008

Journal Articles

PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

Ryo Yamamoto, Momoko Nishikori, Toshio Kitawaki, Tomomi Sakai, Masakatsu Hishizawa, Masaharu Tashima, Tadakazu Kondo, Katsuyuki Ohmori, Masayuki Kurata, Takamasa Hayashi, Takashi Uchiyama

Blood (2008) 111 (6): 3220–3224.

https://doi.org/10.1182/blood-2007-05-085159

Published: 2008

Includes: Supplemental data

Journal Articles

PD-1/PD-1-Ligand Interaction Contributes to Immunosuppressive Microenvironment of Hodgkin Lymphoma.

Ryo Yamamoto, Momoko Nishikori, Toshio Kitawaki, Tomomi Sakai, Masakatsu Hishizawa, Masaharu Tashima, Tadakazu Kondo, Katsuyuki Ohmori, Takashi Uchiyama

Blood (2007) 110 (11): 379.

https://doi.org/10.1182/blood.V110.11.379.379

Published: 2007

Journal Articles

Shared and Differential Gene Expression Profiles between Anaplastic Large Cell Lymphoma and Hodgkin Lymphoma Revealed by Supervised Clustering Analyses.

Yoshitomo Maesako, Momoko Nishikori, Hitoshi Ohno, Takashi Uchiyama

Blood (2004) 104 (11): 4303.

https://doi.org/10.1182/blood.V104.11.4303.4303

Published: 2004

Journal Articles

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

Momoko Nishikori, Yoshitomo Maesako, Chiyoko Ueda, Masayuki Kurata, Takashi Uchiyama, Hitoshi Ohno

Blood (2003) 101 (7): 2789–2796.

https://doi.org/10.1182/blood-2002-08-2464

Published: 2003

NARROW

A Multicenter, Prospective, Observational Study of Pola-R-CHP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (POLASTAR): A Preliminary Analysis

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Screening for Intracellular Phosphorylation Cascades That Positively and Negatively Regulate the Self-Renewing Proliferation of Immature HPCs

Enhancement of Human Neutrophil Bactericidal Activity through ROS Regulation

LUBAC accelerates B-cell lymphomagenesis by conferring resistance to genotoxic stress on B cells

End-of-Treatment 18[F]-FDG PET Can Predict Progression-Free Survival in Patients Undergoing Bendamustine + Rituximab for First Relapsed/Recurrent Follicular Lymphoma: The Result of W- J H S NHL01 Study

Clinical Analysis of Immunodeficiency-Associated Lymphoproliferative Disorders in a Single Institution

Mechanisms Underlying Augmented Lymphomagenesis by LUBAC; Possible Accumulation of AID-Mediated Somatic Mutations

Notch1-Activated B Cells Have an Immunomodulatory Function Enhancing Th2 and Treg Immune Response Via IL-33-ST2 Pathway

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Expression of Tim-1 and Its Pathogenetic Role in Primary CNS Lymphoma

STX11 Acts As a Novel Tumor Suppressor Gene in Peripheral T-Cell Lymphomas

Ki-67 Is a Strong Predictor for Central Nervous System Relapse in Patients with Mantle Cell Lymphoma (MCL)

Deregulation of CCND1 or BCL2 in the Immature B-Cell Stage Determines the Resulting Lymphoma Histology

Idiopathic CD4 Lymphocytopenia Due to Loss of Heterozygosity of the Mutant CD2 Gene

B Cells with BCL2/IGH Translocation Compose a Distinctive Cell Population That May Serve as a Reservoir of Lymphoma of Germinal Center B-Cell Type.

PD-1–PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma

PD-1/PD-1-Ligand Interaction Contributes to Immunosuppressive Microenvironment of Hodgkin Lymphoma.

Shared and Differential Gene Expression Profiles between Anaplastic Large Cell Lymphoma and Hodgkin Lymphoma Revealed by Supervised Clustering Analyses.

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only